Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system.
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D001798:Blood Proteins / Q000096:biosynthesis; D005900:Glaucarubin / Q000031:analogs & derivatives / Q000494:pharmacology*; D066298:In Vitro Techniques; D010616:Phenanthrenes / Q000494:pharmacology*; D014176:Protein Biosynthesis; D036702:Quassins; D011817:Rabbits; D012156:Reticulocytes / Q000378:metabolism*
D000972:Antineoplastic Agents, Phytogenic; D001798:Blood Proteins; D010616:Phenanthrenes; D036702:Quassins; C020237:brusatol; D005900:Glaucarubin; C002550:bruceantin